D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
URGN holding history
UroGen Pharma Ltd. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
URGN overviewAll 13F holders of URGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,145,819
- Value
- $42.2M
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,145,819 | $42.2M | <0.1% | +122,660+12.0% | Added | Holders |
| Q1 2026 | 1,023,159 | $18.4M | <0.1% | +60,535+6.3% | Added | Holders |
| Q4 2025 | 962,624 | $22.5M | <0.1% | +73,691+8.3% | Added | Holders |
| Q3 2025 | 888,933 | $17.7M | <0.1% | +861,501+3,140.5% | Added | Holders |
| Q2 2025 | 27,432 | $375.8K | <0.1% | +27,432 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −10,843−100.0% | Sold out | Holders |
| Q2 2024 | 10,843 | $181.9K | <0.1% | +10,843 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −77,873−100.0% | Sold out | Holders |
| Q4 2023 | 77,873 | $1.17M | <0.1% | +44,240+131.5% | Added | Holders |
| Q3 2023 | 33,633 | $471.2K | <0.1% | +33,633 | New | Holders |